Karen Prange, SVP&Pres, Uro & Women's Health at BOSTON SCIENTIFIC CORP (BSX), sold 2,492 shares at $16.79 ($42K) on 2015-03-03, disclosed to the SEC on 2015-03-04.
Scheduled sale ($42k) by SVP&Pres, Uro & Women's Health under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2025-03-07 | $465K | — | Filing → |
| VRAY | SELL | 2023-07-21 | $9K | — | Filing → |
| ATRC | SELL | 2023-06-12 | $34K | — | Filing → |